Fajgenbaum David C, Shilling Dustin
Division of Translational Medicine and Human Genetics, Hospital of the University of Pennsylvania, 3400 Spruce Street, Silverstein 5, Suite S05094, Philadelphia, PA 19104, USA.
Division of Translational Medicine and Human Genetics, Hospital of the University of Pennsylvania, 3400 Spruce Street, Silverstein 5, Suite S05094, Philadelphia, PA 19104, USA.
Hematol Oncol Clin North Am. 2018 Feb;32(1):11-21. doi: 10.1016/j.hoc.2017.09.002.
Castleman disease (CD) describes a group of heterogeneous disorders with common lymph node histopathologic features, including atrophic or hyperplastic germinal centers, prominent follicular dendritic cells, hypervascularization, polyclonal lymphoproliferation, and/or polytypic plasmacytosis. The cause and pathogenesis of the four subtypes of CD (unicentric CD; human herpesvirus-8-associated multicentric CD; polyradiculoneuropathy, organomegaly, endocrinopathy, monoclonal plasma cell disorder, and skin changes [POEMS]-associated multicentric CD; and idiopathic multicentric CD) vary considerably. This article provides a summary of our current understanding of the cause, cell types, signaling pathways, and effector cytokines implicated in the pathogenesis of each subtype.
Castleman病(CD)是一组具有共同淋巴结组织病理学特征的异质性疾病,包括萎缩或增生的生发中心、显著的滤泡树突状细胞、血管增生、多克隆淋巴细胞增殖和/或多型性浆细胞增多。CD的四种亚型(单中心性CD;人疱疹病毒8型相关多中心性CD;多神经根神经病、器官肿大、内分泌病、单克隆浆细胞病和皮肤改变[POEMS]相关多中心性CD;以及特发性多中心性CD)的病因和发病机制差异很大。本文总结了我们目前对每种亚型发病机制中涉及的病因、细胞类型、信号通路和效应细胞因子的理解。